EANM'05 ISTANBUL - Continuing Medical Education Evaluation

346 views

Published on

Published in: Health & Medicine, Education
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
346
On SlideShare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
1
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

EANM'05 ISTANBUL - Continuing Medical Education Evaluation

  1. 1. EANM'05 ISTANBUL - Continuing Medical Education Evaluation CME Evaluation Form - Session: 1 Received CME Forms: 181 Session Title: ENDOCRINOLOGY (Nuclear medicine in Endocrine Diseases) Session Time, Date: Sunday, 07:00 - 09:30 1 = excellent, 2 = good, 3 = acceptable, 4 = inadequate Question I. Igerc A. Kurtaran R.P.Baum Received Answers for this Session Organizational and logical level of the presentation 1,72 1,60 1,36 Ability of speaker to keep my interest during the session 1,99 1,79 1,48 Relevance of lecture to my clinical practice and/or research 1,87 1,97 1,99 Ability of faculty to prompt critical thought about the subject matter 1,99 1,78 1,67 Ability of speaker to provoke critical thoughts on the subject 2,09 1,85 1,72 The novelty of the content 2,32 1,82 1,41 Impact on my daily practice 2,15 2,19 2,16 The overall value of this session as a learning experience 1,94 1,74 1,51 CME Session I TOTAL CME 2005: 584 Attendees ENDOCRINOLOGY (Nuclear medicine in Endocrine Diseases) 181 at CME I: ENDOCRINOLOGY (NM in Endocrine Diseases) Sunday, 07:00 - 09:30 246 at CME II: ONCOLOGY PET/CT (Current role of PET and PET/CT in …) 186 at CME III: ONCOLOGY (The role of NM in Gastroenterop. …) Moderator: R.P. Baum (Bad Berka) 160 at CME IV: THERAPY (Interventional Radionuclide Therapy) Co-Moderator: P. Lind (Klagenfurt) 200 at CME V: CARDIOLOGY (NC for left ventricular dysfunction) Speakers: 245 at CME VI: ORTHOPEDICS (Nuc. orthopedics today: old and new ….) I. Igerc (Klagenfurt): The role of NM in thyroid and parathyroid diseases 175 at CME VII: PAEDIATRICS (PET in Paediatrics) A. Kurtaran (Vienna): Nuclear imaging of adrenal glands 107 at CME VIII: NEUROLOGY (EANM-SNM Joint Seminar) R.P. Baum (Bad Berka): The role of PET and PET/CT for the molecular diagnosis of neuroendocrine tumours 222 at CME IX: INTERACTIVE NUCLEAR MEDICINE AND PET and clinical experience with Peptide Receptor Radionuclide Therapy (PRRT) using radiolabelled somatostatin 223 at CME X: INTERACTIVE CARDIOLOGY (Cases in Cardiology) analogs in over 200 patients. 132 at CME XI: INTERACTIVE NEUROLOGY (Case Pres. in Neurology) 100 at CME XII: PHYSICS (Quality and Regulatory issues in Nuclear Medicin 125 at CME XIII: RADIOPHARMACY (Radiopharmac. chemistry of SPECT… Page: 1/13
  2. 2. EANM'05 ISTANBUL - Continuing Medical Education Evaluation CME Evaluation Form - Session: 2 Received CME Forms: 246 Session Title: ONCOLOGY PET/CT (Current role of PET and PET/CT in …) Session Time, Date: Sunday, 11:30 - 13:00 1 = excellent, 2 = good, 3 = acceptable, 4 = inadequate Question E. Morra J.N. Talbot O. Schober Received Answers for this Session Organizational and logical level of the presentation 1,98 1,88 1,97 Ability of speaker to keep my interest during the session 2,42 1,84 2,28 Relevance of lecture to my clinical practice and/or research 2,32 2,08 2,29 Ability of faculty to prompt critical thought about the subject matter 2,28 1,95 2,22 Ability of speaker to provoke critical thoughts on the subject 2,36 1,95 2,23 The novelty of the content 2,30 2,01 2,13 Impact on my daily practice 2,54 2,20 2,36 The overall value of this session as a learning experience 2,24 1,90 2,13 CME Session II TOTAL CME 2005: 584 Attendees ONCOLOGY PET/CT (Current role of PET and PET/CT in managing lymphoma patients) 181 at CME I: ENDOCRINOLOGY (NM in Endocrine Diseases) Sunday, 11:30 - 13:00 246 at CME II: ONCOLOGY PET/CT (Current role of PET and PET/CT in …) 186 at CME III: ONCOLOGY (The role of NM in Gastroenterop. …) Moderator: E. Bombardieri (Milan) 160 at CME IV: THERAPY (Interventional Radionuclide Therapy) Co-Moderator: J.N. Talbot (Paris) 200 at CME V: CARDIOLOGY (NC for left ventricular dysfunction) Speakers: 245 at CME VI: ORTHOPEDICS (Nuc. orthopedics today: old and new ….) E. Morra (Milan): Malignant lymphomas: prognostic factors and treatment 175 at CME VII: PAEDIATRICS (PET in Paediatrics) JN Talbot (Paris) : FDG-PET in the diagnosis and staging of lymphoma 107 at CME VIII: NEUROLOGY (EANM-SNM Joint Seminar) O. Schober (Munster): PET/CT in assessing therapy response 222 at CME IX: INTERACTIVE NUCLEAR MEDICINE AND PET 223 at CME X: INTERACTIVE CARDIOLOGY (Cases in Cardiology) 132 at CME XI: INTERACTIVE NEUROLOGY (Case Pres. in Neurology) 100 at CME XII: PHYSICS (Quality and Regulatory issues in Nuclear Medicin 125 at CME XIII: RADIOPHARMACY (Radiopharmac. chemistry of SPECT… Page: 2/13
  3. 3. EANM'05 ISTANBUL - Continuing Medical Education Evaluation CME Evaluation Form - Session: 3 Received CME Forms: 186 Session Title: ONCOLOGY (The role of Nuclear Medicine in Gastroenterop. …) Session Time, Date: Sunday, 14:30 - 16:00 1 = excellent, 2 = good, 3 = acceptable, 4 = inadequate Question E. Bombardieri W. Langsteger I. Virgolini Received Answers for this Session Organizational and logical level of the presentation 1,85 1,85 2,02 Ability of speaker to keep my interest during the session 2,12 2,11 2,19 Relevance of lecture to my clinical practice and/or research 2,05 2,21 2,41 Ability of faculty to prompt critical thought about the subject matter 2,12 2,14 2,19 Ability of speaker to provoke critical thoughts on the subject 2,13 2,14 2,16 The novelty of the content 2,15 1,90 1,93 Impact on my daily practice 2,27 2,32 2,53 The overall value of this session as a learning experience 2,09 2,02 2,04 CME Session III TOTAL CME 2005: 584 Attendees ONCOLOGY (The role of Nuclear Medicine in Gastroenteropancreatic (GEP) tumours) 181 at CME I: ENDOCRINOLOGY (NM in Endocrine Diseases) Sunday, 14:30 - 16:00 246 at CME II: ONCOLOGY PET/CT (Current role of PET and PET/CT in …) 186 at CME III: ONCOLOGY (The role of NM in Gastroenterop. …) Moderator: F. Pons (Barcelona) 160 at CME IV: THERAPY (Interventional Radionuclide Therapy) Co-Moderator: W. Langsteger (Linz) 200 at CME V: CARDIOLOGY (NC for left ventricular dysfunction) Speakers: 245 at CME VI: ORTHOPEDICS (Nuc. orthopedics today: old and new ….) E. Bombardieri (Milan): Receptor scintigraphy for imaging GEP tumours 175 at CME VII: PAEDIATRICS (PET in Paediatrics) W. Langsteger (Linz): Current status of PET in GEP tumors 107 at CME VIII: NEUROLOGY (EANM-SNM Joint Seminar) I. Virgolini (Innsbruck): Radionuclide Therapy of GEP Tumours 222 at CME IX: INTERACTIVE NUCLEAR MEDICINE AND PET 223 at CME X: INTERACTIVE CARDIOLOGY (Cases in Cardiology) 132 at CME XI: INTERACTIVE NEUROLOGY (Case Pres. in Neurology) 100 at CME XII: PHYSICS (Quality and Regulatory issues in Nuclear Medicin 125 at CME XIII: RADIOPHARMACY (Radiopharmac. chemistry of SPECT… Page: 3/13
  4. 4. EANM'05 ISTANBUL - Continuing Medical Education Evaluation CME Evaluation Form - Session: 4 Received CME Forms: 160 Session Title: THERAPY (Interventional Radionuclide Therapy) Session Time, Date: Sunday, 16:30 - 17:00 1 = excellent, 2 = good, 3 = acceptable, 4 = inadequate Question L. Kabasakal K. Tatsch G. Paganelli Received Answers for this Session Organizational and logical level of the presentation 1,55 1,64 1,46 Ability of speaker to keep my interest during the session 1,69 1,89 1,53 Relevance of lecture to my clinical practice and/or research 1,68 2,47 1,90 Ability of faculty to prompt critical thought about the subject matter 1,85 2,00 1,75 Ability of speaker to provoke critical thoughts on the subject 1,75 1,86 1,70 The novelty of the content 1,86 1,74 1,51 Impact on my daily practice 1,79 2,52 2,09 The overall value of this session as a learning experience 1,68 1,84 1,60 CME Session IV TOTAL CME 2005: 584 Attendees THERAPY (Interventional Radionuclide Therapy) 181 at CME I: ENDOCRINOLOGY (NM in Endocrine Diseases) Sunday, 16:30 - 17:00 246 at CME II: ONCOLOGY PET/CT (Current role of PET and PET/CT in …) 186 at CME III: ONCOLOGY (The role of NM in Gastroenterop. …) Moderator: C.A. Hoefnagel (Amsterdam) 160 at CME IV: THERAPY (Interventional Radionuclide Therapy) Co-Moderator: B. Brans (Heerlen) 200 at CME V: CARDIOLOGY (NC for left ventricular dysfunction) Speakers: 245 at CME VI: ORTHOPEDICS (Nuc. orthopedics today: old and new ….) L. Kabasakal (Istanbul): Pharmacological interventions in radioiodine-negative thyroid carcinoma 175 at CME VII: PAEDIATRICS (PET in Paediatrics) K. Tatsch (Munich): Radionuclide therapy by direct intratumoural / intracystic approach 107 at CME VIII: NEUROLOGY (EANM-SNM Joint Seminar) G. Paganelli (Milan): Contribution of interventional nuclear medicine in early breast cancer: from ROLL 222 at CME IX: INTERACTIVE NUCLEAR MEDICINE AND PET (Radioguided Occult Lesion Localization to IART® (Intra-operative Avidination for Radionuclide Therapy) 223 at CME X: INTERACTIVE CARDIOLOGY (Cases in Cardiology) 132 at CME XI: INTERACTIVE NEUROLOGY (Case Pres. in Neurology) 100 at CME XII: PHYSICS (Quality and Regulatory issues in Nuclear Medicin 125 at CME XIII: RADIOPHARMACY (Radiopharmac. chemistry of SPECT… Page: 4/13
  5. 5. EANM'05 ISTANBUL - Continuing Medical Education Evaluation CME Evaluation Form - Session: 5 Received CME Forms: 200 Session Title: CARDIOLOGY (Role of nuclear cardiology in patients with left …) Session Time, Date: Monday, 07:00 - 09:30 1 = excellent, 2 = good, 3 = acceptable, 4 = inadequate Question G. Sambuceti R. Sciagra H. Schelbert Received Answers for this Session Organizational and logical level of the presentation 1,60 1,64 1,41 Ability of speaker to keep my interest during the session 1,77 1,77 1,58 Relevance of lecture to my clinical practice and/or research 1,93 1,74 1,93 Ability of faculty to prompt critical thought about the subject matter 1,84 1,82 1,74 Ability of speaker to provoke critical thoughts on the subject 1,80 1,87 1,76 The novelty of the content 1,85 1,90 1,82 Impact on my daily practice 2,05 1,84 2,14 The overall value of this session as a learning experience 1,75 1,75 1,66 CME Session V TOTAL CME 2005: 584 Attendees CARDIOLOGY (Role of nuclear cardiology in patients with left ventricular dysfunction) 181 at CME I: ENDOCRINOLOGY (NM in Endocrine Diseases) Monday, 07:00 - 09:30 246 at CME II: ONCOLOGY PET/CT (Current role of PET and PET/CT in …) 186 at CME III: ONCOLOGY (The role of NM in Gastroenterop. …) Moderator: F. Bengel (Munich) 160 at CME IV: THERAPY (Interventional Radionuclide Therapy) Co-Moderator: A. Cuocolo (Naples) 200 at CME V: CARDIOLOGY (NC for left ventricular dysfunction) Speakers: 245 at CME VI: ORTHOPEDICS (Nuc. orthopedics today: old and new ….) G. Sambuceti (Genova): Pathophysiology of chronic dysfunction in viable myocardium 175 at CME VII: PAEDIATRICS (PET in Paediatrics) R. Sciagrà (Florence) : The role of SPECT and gated Swith Parkinson's disease and other neurodegenerative disorders 107 at CME VIII: NEUROLOGY (EANM-SNM Joint Seminar) H. Schelbert ( Los Angeles): The role of PET 222 at CME IX: INTERACTIVE NUCLEAR MEDICINE AND PET 223 at CME X: INTERACTIVE CARDIOLOGY (Cases in Cardiology) 132 at CME XI: INTERACTIVE NEUROLOGY (Case Pres. in Neurology) 100 at CME XII: PHYSICS (Quality and Regulatory issues in Nuclear Medicin 125 at CME XIII: RADIOPHARMACY (Radiopharmac. chemistry of SPECT… Page: 5/13
  6. 6. EANM'05 ISTANBUL - Continuing Medical Education Evaluation CME Evaluation Form - Session: 6 Received CME Forms: 245 Session Title: ORTHOPEDICS (Nuclear orthopedics today: old and new ….) Session Time, Date: Monday, 11:30 - 13:00 1 = excellent, 2 = good, 3 = acceptable, 4 = inadequate Question L. Mansi T. Varetto L. Kabasakal Received Answers for this Session Organizational and logical level of the presentation 1,94 1,59 2,08 Ability of speaker to keep my interest during the session 2,02 1,61 2,30 Relevance of lecture to my clinical practice and/or research 2,05 1,66 2,08 Ability of faculty to prompt critical thought about the subject matter 2,17 1,85 2,24 Ability of speaker to provoke critical thoughts on the subject 2,16 1,81 2,31 The novelty of the content 2,25 1,97 2,36 Impact on my daily practice 2,11 1,76 2,13 The overall value of this session as a learning experience 2,11 1,68 2,23 CME Session VI TOTAL CME 2005: 584 Attendees ORTHOPEDICS (Nuclear orthopedics today: old and new procedures and indications ) 181 at CME I: ENDOCRINOLOGY (NM in Endocrine Diseases) Monday, 11:30 - 13:00 246 at CME II: ONCOLOGY PET/CT (Current role of PET and PET/CT in …) 186 at CME III: ONCOLOGY (The role of NM in Gastroenterop. …) Moderator: L. Mansi (Naples) 160 at CME IV: THERAPY (Interventional Radionuclide Therapy) Co-Moderator: L. Kabasakal (Istanbul) 200 at CME V: CARDIOLOGY (NC for left ventricular dysfunction) Speakers: 245 at CME VI: ORTHOPEDICS (Nuc. orthopedics today: old and new ….) L. Mansi (Naples): Pathophysiological premises and procedures 175 at CME VII: PAEDIATRICS (PET in Paediatrics) T. Varetto (Turin): The role in benign diseases 107 at CME VIII: NEUROLOGY (EANM-SNM Joint Seminar) L. Kabasakal (Istanbul): The role in malignancy 222 at CME IX: INTERACTIVE NUCLEAR MEDICINE AND PET 223 at CME X: INTERACTIVE CARDIOLOGY (Cases in Cardiology) 132 at CME XI: INTERACTIVE NEUROLOGY (Case Pres. in Neurology) 100 at CME XII: PHYSICS (Quality and Regulatory issues in Nuclear Medicin 125 at CME XIII: RADIOPHARMACY (Radiopharmac. chemistry of SPECT… Page: 6/13
  7. 7. EANM'05 ISTANBUL - Continuing Medical Education Evaluation CME Evaluation Form - Session: 7 Received CME Forms: 175 Session Title: PAEDIATRICS (PET in Paediatrics) Session Time, Date: Monday, 14:30 - 16:00 1 = excellent, 2 = good, 3 = acceptable, 4 = inadequate Question L. Borgwardt T. Pfluger C. Franzius Received Answers for this Session Organizational and logical level of the presentation 1,79 1,74 1,69 Ability of speaker to keep my interest during the session 2,03 1,90 1,92 Relevance of lecture to my clinical practice and/or research 2,14 2,02 2,06 Ability of faculty to prompt critical thought about the subject matter 1,99 1,92 1,88 Ability of speaker to provoke critical thoughts on the subject 2,06 1,98 1,88 The novelty of the content 1,93 1,85 1,75 Impact on my daily practice 2,25 2,20 2,24 The overall value of this session as a learning experience 1,94 1,86 1,85 CME Session VII TOTAL CME 2005: 584 Attendees PAEDIATRICS (PET in Paediatrics) 181 at CME I: ENDOCRINOLOGY (NM in Endocrine Diseases) Monday, 14:30 - 16:00 246 at CME II: ONCOLOGY PET/CT (Current role of PET and PET/CT in …) 186 at CME III: ONCOLOGY (The role of NM in Gastroenterop. …) Moderator: K. Hahn (Munich) 160 at CME IV: THERAPY (Interventional Radionuclide Therapy) Co-Moderator: L. Biassoni (London) 200 at CME V: CARDIOLOGY (NC for left ventricular dysfunction) Speakers: 245 at CME VI: ORTHOPEDICS (Nuc. orthopedics today: old and new ….) L. Borgwardt (Copenhagen): Patient preparation, imaging procedure and pitfalls in paediatric PET 175 at CME VII: PAEDIATRICS (PET in Paediatrics) T. Pfluger (Munich): Multimodality imaging in paediatric oncology with emphasis on PET in lymphoma 107 at CME VIII: NEUROLOGY (EANM-SNM Joint Seminar) C. Franzius (Munster): PET in pediatric solid tumors 222 at CME IX: INTERACTIVE NUCLEAR MEDICINE AND PET 223 at CME X: INTERACTIVE CARDIOLOGY (Cases in Cardiology) 132 at CME XI: INTERACTIVE NEUROLOGY (Case Pres. in Neurology) 100 at CME XII: PHYSICS (Quality and Regulatory issues in Nuclear Medicin 125 at CME XIII: RADIOPHARMACY (Radiopharmac. chemistry of SPECT… Page: 7/13
  8. 8. EANM'05 ISTANBUL - Continuing Medical Education Evaluation CME Evaluation Form - Session: 8 Received CME Forms: 107 Session Title: NEUROLOGY (EANM-SNM Joint Seminar) Session Time, Date: Monday, 16:30 - 17:00 1 = excellent, 2 = good, 3 = acceptable, 4 = inadequate Question F. Nobili M. Devous S. Minoshima Received Answers for this Session Organizational and logical level of the presentation 1,61 1,92 1,57 Ability of speaker to keep my interest during the session 1,86 1,94 1,72 Relevance of lecture to my clinical practice and/or research 1,97 2,31 1,97 Ability of faculty to prompt critical thought about the subject matter 1,93 2,14 1,74 Ability of speaker to provoke critical thoughts on the subject 1,99 1,97 1,76 The novelty of the content 1,74 1,92 1,65 Impact on my daily practice 2,09 2,31 2,09 The overall value of this session as a learning experience 1,74 1,94 1,65 CME Session VIII TOTAL CME 2005: 584 Attendees NEUROLOGY (EANM-SNM Joint Sem.: Dementia imaging: metabolism, blood flow & beyond) 181 at CME I: ENDOCRINOLOGY (NM in Endocrine Diseases) Monday, 16:30 - 17:00 246 at CME II: ONCOLOGY PET/CT (Current role of PET and PET/CT in …) 186 at CME III: ONCOLOGY (The role of NM in Gastroenterop. …) 160 at CME IV: THERAPY (Interventional Radionuclide Therapy) Moderator: K. Tatsch (Munich) 200 at CME V: CARDIOLOGY (NC for left ventricular dysfunction) Co-Moderator: F. Nobili (Genova) 245 at CME VI: ORTHOPEDICS (Nuc. orthopedics today: old and new ….) Speakers: 175 at CME VII: PAEDIATRICS (PET in Paediatrics) F. Nobili (Genoa): Pathophysiology and Clinical Features of Dementia 107 at CME VIII: NEUROLOGY (EANM-SNM Joint Seminar) M. Devous (Dallas): Metabolism and Perfusion Studies in Evaluation of Dementia 222 at CME IX: INTERACTIVE NUCLEAR MEDICINE AND PET S. Minoshima (Seattle): Neuroimaging of Dementia: Clinical Indication, Research, and Future 223 at CME X: INTERACTIVE CARDIOLOGY (Cases in Cardiology) 132 at CME XI: INTERACTIVE NEUROLOGY (Case Pres. in Neurology) 100 at CME XII: PHYSICS (Quality and Regulatory issues in Nuclear Medicin 125 at CME XIII: RADIOPHARMACY (Radiopharmac. chemistry of SPECT… Page: 8/13
  9. 9. EANM'05 ISTANBUL - Continuing Medical Education Evaluation CME Evaluation Form - Session: 9 Received CME Forms: 222 Session Title: INTERACTIVE NUCLEAR MEDICINE AND PET Session Time, Date: Tuesday, 07:00 - 09:30 1 = excellent, 2 = good, 3 = acceptable, 4 = inadequate Question F. Paycha W. Langsteger Received Answers for this Session Organizational and logical level of the presentation 1,70 1,83 Ability of speaker to keep my interest during the session 1,70 1,94 Relevance of lecture to my clinical practice and/or research 1,78 2,00 Ability of faculty to prompt critical thought about the subject matter 1,77 1,95 Ability of speaker to provoke critical thoughts on the subject 1,78 1,99 The novelty of the content 1,93 1,92 Impact on my daily practice 1,89 2,06 The overall value of this session as a learning experience 1,73 1,88 CME Session IX TOTAL CME 2005: 584 Attendees INTERACTIVE NUCLEAR MEDICINE AND PET (Interesting clinical cases) 181 at CME I: ENDOCRINOLOGY (NM in Endocrine Diseases) Tuesday, 07:00 - 09:30 246 at CME II: ONCOLOGY PET/CT (Current role of PET and PET/CT in …) 186 at CME III: ONCOLOGY (The role of NM in Gastroenterop. …) Moderator: J. N. Talbot (Paris) 160 at CME IV: THERAPY (Interventional Radionuclide Therapy) Co-Moderator: 200 at CME V: CARDIOLOGY (NC for left ventricular dysfunction) Speakers: 245 at CME VI: ORTHOPEDICS (Nuc. orthopedics today: old and new ….) F. Paycha (Colombes) 175 at CME VII: PAEDIATRICS (PET in Paediatrics) W. Langsteger (Linz) 107 at CME VIII: NEUROLOGY (EANM-SNM Joint Seminar) T. Hany (Zürich) 222 at CME IX: INTERACTIVE NUCLEAR MEDICINE AND PET 223 at CME X: INTERACTIVE CARDIOLOGY (Cases in Cardiology) 132 at CME XI: INTERACTIVE NEUROLOGY (Case Pres. in Neurology) 100 at CME XII: PHYSICS (Quality and Regulatory issues in Nuclear Medicin 125 at CME XIII: RADIOPHARMACY (Radiopharmac. chemistry of SPECT… Page: 9/13
  10. 10. EANM'05 ISTANBUL - Continuing Medical Education Evaluation CME Evaluation Form - Session: 10 Received CME Forms: 223 Session Title: INTERACTIVE CARDIOLOGY (Cases in Cardiology) Session Time, Date: Tuesday, 11:30 - 13:00 1 = excellent, 2 = good, 3 = acceptable, 4 = inadequate Question R. Underwood D. Berman Received Answers for this Session Organizational and logical level of the presentation 1,41 1,73 Ability of speaker to keep my interest during the session 1,40 1,87 Relevance of lecture to my clinical practice and/or research 1,52 1,87 Ability of faculty to prompt critical thought about the subject matter 1,53 1,79 Ability of speaker to provoke critical thoughts on the subject 1,52 1,77 The novelty of the content 1,74 1,76 Impact on my daily practice 1,66 1,98 The overall value of this session as a learning experience 1,49 1,77 CME Session X TOTAL CME 2005: 584 Attendees INTERACTIVE CARDIOLOGY (Interactive Case Presentations in Cardiology) 181 at CME I: ENDOCRINOLOGY (NM in Endocrine Diseases) Tuesday, 11:30 - 13:00 246 at CME II: ONCOLOGY PET/CT (Current role of PET and PET/CT in …) 186 at CME III: ONCOLOGY (The role of NM in Gastroenterop. …) Moderator: A. Cuocolo (Naples) 160 at CME IV: THERAPY (Interventional Radionuclide Therapy) Co-Moderator: 200 at CME V: CARDIOLOGY (NC for left ventricular dysfunction) Speakers: 245 at CME VI: ORTHOPEDICS (Nuc. orthopedics today: old and new ….) R. Underwood (London): Case readings - standardized interpretation, pearls and pitfalls 175 at CME VII: PAEDIATRICS (PET in Paediatrics) D. Berman (Los Angeles): Case readings nuclear and CT - multimodality approach for CAD workup 107 at CME VIII: NEUROLOGY (EANM-SNM Joint Seminar) 222 at CME IX: INTERACTIVE NUCLEAR MEDICINE AND PET 223 at CME X: INTERACTIVE CARDIOLOGY (Cases in Cardiology) 132 at CME XI: INTERACTIVE NEUROLOGY (Case Pres. in Neurology) 100 at CME XII: PHYSICS (Quality and Regulatory issues in Nuclear Medicin 125 at CME XIII: RADIOPHARMACY (Radiopharmac. chemistry of SPECT… Page: 10/13
  11. 11. EANM'05 ISTANBUL - Continuing Medical Education Evaluation CME Evaluation Form - Session: 11 Received CME Forms: 132 Session Title: INTERACTIVE NEUROLOGY (Case Presentations in Neurology) Session Time, Date: Tuesday, 14:30 - 16:00 1 = excellent, 2 = good, 3 = acceptable, 4 = inadequate Question K. Tatsch K. Herholz W. van Paesschen Received Answers for this Session Organizational and logical level of the presentation 1,32 1,65 1,93 Ability of speaker to keep my interest during the session 1,48 1,71 2,15 Relevance of lecture to my clinical practice and/or research 1,71 2,12 2,56 Ability of faculty to prompt critical thought about the subject matter 1,63 1,88 2,42 Ability of speaker to provoke critical thoughts on the subject 1,56 1,77 2,33 The novelty of the content 1,56 1,80 2,04 Impact on my daily practice 2,00 2,35 2,63 The overall value of this session as a learning experience 1,58 1,81 2,19 CME Session XI TOTAL CME 2005: 584 Attendees INTERACTIVE NEUROLOGY (Case Presentations in Neurology) 181 at CME I: ENDOCRINOLOGY (NM in Endocrine Diseases) Tuesday, 14:30 - 16:00 246 at CME II: ONCOLOGY PET/CT (Current role of PET and PET/CT in …) 186 at CME III: ONCOLOGY (The role of NM in Gastroenterop. …) Moderator: Ö. Kapucu (Ankara) 160 at CME IV: THERAPY (Interventional Radionuclide Therapy) Co-Moderator: K. Tatsch (Munich) 200 at CME V: CARDIOLOGY (NC for left ventricular dysfunction) Speakers: 245 at CME VI: ORTHOPEDICS (Nuc. orthopedics today: old and new ….) K. Tatsch (Munich): Pitfalls in Neuroimaging 175 at CME VII: PAEDIATRICS (PET in Paediatrics) K. Herholz (Cologne): Brain Tumors 107 at CME VIII: NEUROLOGY (EANM-SNM Joint Seminar) W. van Paesschen (Leuven): Epilepsy 222 at CME IX: INTERACTIVE NUCLEAR MEDICINE AND PET 223 at CME X: INTERACTIVE CARDIOLOGY (Cases in Cardiology) 132 at CME XI: INTERACTIVE NEUROLOGY (Case Pres. in Neurology) 100 at CME XII: PHYSICS (Quality and Regulatory issues in Nuclear Medicin 125 at CME XIII: RADIOPHARMACY (Radiopharmac. chemistry of SPECT… Page: 11/13
  12. 12. EANM'05 ISTANBUL - Continuing Medical Education Evaluation CME Evaluation Form - Session: 12 Received CME Forms: 100 Session Title: PHYSICS (Quality and Regulatory issues in Nuclear Medicine) Session Time, Date: Wednesday, 07:00 - 09:30 1 = excellent, 2 = good, 3 = acceptable, 4 = inadequate Question S. Ebdon-Jackson C. Chiesa H. Bergmann Received Answers for this Session Organizational and logical level of the presentation 1,52 1,62 1,61 Ability of speaker to keep my interest during the session 1,76 1,79 1,87 Relevance of lecture to my clinical practice and/or research 1,91 1,72 2,06 Ability of faculty to prompt critical thought about the subject matter 1,84 1,84 1,99 Ability of speaker to provoke critical thoughts on the subject 1,90 1,92 1,92 The novelty of the content 1,95 1,93 1,79 Impact on my daily practice 1,86 1,85 2,20 The overall value of this session as a learning experience 1,74 1,75 1,83 CME Session XII TOTAL CME 2005: 584 Attendees PHYSICS (Quality and Regulatory issues in Nuclear Medicine) 181 at CME I: ENDOCRINOLOGY (NM in Endocrine Diseases) Wednesday, 07:00 - 09:30 246 at CME II: ONCOLOGY PET/CT (Current role of PET and PET/CT in …) 186 at CME III: ONCOLOGY (The role of NM in Gastroenterop. …) Moderator: A. Britten (London) 160 at CME IV: THERAPY (Interventional Radionuclide Therapy) Co-Moderator: H. Bergmann (Vienna) 200 at CME V: CARDIOLOGY (NC for left ventricular dysfunction) Speakers: 245 at CME VI: ORTHOPEDICS (Nuc. orthopedics today: old and new ….) S. Ebdon-Jackson (Oxford): The Regulatory Position in Europe: A British Perspective 175 at CME VII: PAEDIATRICS (PET in Paediatrics) C. Chiesa (Milan): Quality issues with Nuclear Medicine equipment: Gamma Cameras 107 at CME VIII: NEUROLOGY (EANM-SNM Joint Seminar) H. Bergmann (Vienna): Quality issues with PET and PET-CT in 2005 222 at CME IX: INTERACTIVE NUCLEAR MEDICINE AND PET 223 at CME X: INTERACTIVE CARDIOLOGY (Cases in Cardiology) 132 at CME XI: INTERACTIVE NEUROLOGY (Case Pres. in Neurology) 100 at CME XII: PHYSICS (Quality and Regulatory issues in Nuclear Medicin 125 at CME XIII: RADIOPHARMACY (Radiopharmac. chemistry of SPECT… Page: 12/13
  13. 13. EANM'05 ISTANBUL - Continuing Medical Education Evaluation CME Evaluation Form - Session: 13 Received CME Forms: 125 Session Title: RADIOPHARMACY (Radiopharmaceutical chemistry of SPECT…) Session Time, Date: Wednesday, 10:00 - 11:30 1 = excellent, 2 = good, 3 = acceptable, 4 = inadequate Question A. Verbruggen S. Guhlke H. Maecke Received Answers for this Session Organizational and logical level of the presentation 1,60 1,72 1,58 Ability of speaker to keep my interest during the session 1,82 2,06 1,87 Relevance of lecture to my clinical practice and/or research 2,04 2,24 2,11 Ability of faculty to prompt critical thought about the subject matter 1,80 2,07 1,88 Ability of speaker to provoke critical thoughts on the subject 1,89 2,02 1,88 The novelty of the content 1,79 1,94 1,83 Impact on my daily practice 2,15 2,34 2,18 The overall value of this session as a learning experience 1,88 1,98 1,85 CME Session XIII TOTAL CME 2005: 584 Attendees RADIOPHARMACY (Radiopharmaceutical chemistry of SPECT radionuclides) 181 at CME I: ENDOCRINOLOGY (NM in Endocrine Diseases) Wednesday, 10:00 - 11:30 246 at CME II: ONCOLOGY PET/CT (Current role of PET and PET/CT in …) 186 at CME III: ONCOLOGY (The role of NM in Gastroenterop. …) Moderator: G. Westera (Zurich) 160 at CME IV: THERAPY (Interventional Radionuclide Therapy) Co-Moderator: S. Mather (London) 200 at CME V: CARDIOLOGY (NC for left ventricular dysfunction) Speakers: 245 at CME VI: ORTHOPEDICS (Nuc. orthopedics today: old and new ….) A. Verbruggen (Leuven): Radiopharmaceutical chemistry of technetium and rhenium 175 at CME VII: PAEDIATRICS (PET in Paediatrics) S. Guhlke (Bonn): Radiopharmaceutical Chemistry of Iodine 107 at CME VIII: NEUROLOGY (EANM-SNM Joint Seminar) H. Maecke (Basel): Radiopharmaceutical chemistry of trivalent metals 222 at CME IX: INTERACTIVE NUCLEAR MEDICINE AND PET 223 at CME X: INTERACTIVE CARDIOLOGY (Cases in Cardiology) 132 at CME XI: INTERACTIVE NEUROLOGY (Case Pres. in Neurology) 100 at CME XII: PHYSICS (Quality and Regulatory issues in Nuclear Medicin 125 at CME XIII: RADIOPHARMACY (Radiopharmac. chemistry of SPECT… Page: 13/13

×